Evidence map›Paper›PMID 36769649›Full record

ReviewJournal of clinical medicine2023

Advances in the Clinical Application of Platelet-Rich Plasma in the Foot and Ankle: A Review.

Djandan Tadum Arthur Vithran, Miao He, Wenqing Xie, Anko Elijah Essien, Michael Opoku, Yusheng Li

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Djandan Tadum Arthur VithranDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.ORCID 0000-0003-1066-7266
Miao HeDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Wenqing XieDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Anko Elijah EssienDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Michael OpokuDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Yusheng LiDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous and recombinant biologic substances have been generated as a result of the research into the cellular features of the healing process. Orthobiologics are increasingly being used in sports medicine and musculoskeletal surgery. Nevertheless, clinical data are limited; consequently, further studies are required, particularly in foot and ankle pathologies. This review aims to provide evidence of the most recent literature results and ignite the interest of orthopedic specialists eager for an update about the most current discussion on platelet-rich plasma (PRP) clinical applications in the foot and ankle fields. Previous studies have shown that platelet-rich plasma can be beneficial in treating various conditions, such as chronic foot ulcers, osteoarthritis, Achilles tendinopathy, etc. Despite the positive effects of PRP on various musculoskeletal conditions, more prospective studies are needed to confirm its effectiveness at treating ankle and foot pathologies. In addition to clinical trials, other factors, such as the quality of the research and the procedures involved, must be considered before they can be used in patients. More long-term evaluations are needed to support or oppose its application in treating foot and ankle disorders. We present the most extensive review of PRP's clinical applications in the foot and ankle field.

Indexed as

Achilles tendon pathologyankle osteoarthritisdiabetic foot ulcersfoot and ankleplantar fasciitisplatelet-rich plasmareview

Identifiers

PMID36769649
PMCPMC9917505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.